NEUROENDOCRINE TUMOUR OF THE LUNG

This adverse event was reported 108 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE TUMOUR OF THE LUNG:

# Drug Count
0 EVEROLIMUS 20
1 OCTREOTIDE ACETATE 16
2 ADALIMUMAB 5
3 APIXABAN 5
4 ETOPOSIDE 5
5 FUROSEMIDE 5
6 IBUPROFEN 5
7 LUTETIUM LU 177 DOTATATE 5
8 RISANKIZUMAB-RZAA 5
9 ACETAMINOPHEN 4
See all common drugs associated with NEUROENDOCRINE TUMOUR OF THE LUNG

NEUROENDOCRINE TUMOUR OF THE LUNG is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRODALUMAB 4 0.0019
1 OSILODROSTAT 3 0.0014
2 LISOCABTAGENE MARALEUCEL 1 0.0011
3 DISULFIRAM 1 0.0009
4 LUTETIUM LU 177 DOTATATE 5 0.0009
5 ACITRETIN 4 0.0008
6 ALDESLEUKIN 1 0.0008
7 STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM 1 0.0007
8 SELUMETINIB 1 0.0006
9 OCTREOTIDE ACETATE 16 0.0005
See all drugs enriched for association with NEUROENDOCRINE TUMOUR OF THE LUNG